Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,729 | 29,463 | 25,208 | 10,964 | 9,620 |
| Depreciation Amortization | 985 | 931 | 852 | 860 | 3,449 |
| Income taxes - deferred | 292 | 12 | -321 | 191 | -6,785 |
| Accounts receivable | -2,405 | 306 | -3,276 | -3,999 | 356 |
| Accounts payable and accrued liabilities | -3,123 | -2,295 | -5,485 | -134 | 2,195 |
| Other Working Capital | -4,137 | -2,884 | -3,720 | -7,286 | 6,034 |
| Other Operating Activity | 12,186 | 6,974 | 14,351 | 8,906 | 28,652 |
| Operating Cash Flow | $34,527 | $32,507 | $27,609 | $9,502 | $43,521 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -648 | -1,835 | -1,452 | -324 | -1,128 |
| Purchase Of Investment | -2,718 | N/A | N/A | N/A | -75 |
| Sale Of Investment | N/A | 75 | N/A | 379 | N/A |
| Other Investing Activity | 0 | -7,250 | -4,751 | 0 | 0 |
| Investing Cash Flow | $-3,366 | $-9,010 | $-6,203 | $55 | $-1,203 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,196 | 1,445 |
| Debt Repayment | N/A | N/A | -1,620 | -2,035 | -2,500 |
| Common Stock Issued | 1,858 | 4,392 | 5,214 | 1,705 | 3,492 |
| Common Stock Repurchased | 0 | -12,811 | -24,400 | -12,519 | -24,836 |
| Other Financing Activity | 0 | 0 | 0 | 2,300 | -2,300 |
| Financing Cash Flow | $1,858 | $-8,419 | $-20,806 | $-8,353 | $-24,699 |
| Exchange Rate Effect | -27 | 97 | -175 | 371 | -45 |
| Beginning Cash Position | 101,403 | 86,228 | 85,803 | 84,228 | 66,654 |
| End Cash Position | 134,395 | 101,403 | 86,228 | 85,803 | 84,228 |
| Net Cash Flow | $32,992 | $15,175 | $425 | $1,575 | $17,574 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,527 | 32,507 | 27,609 | 9,502 | 43,521 |
| Capital Expenditure | -648 | -1,835 | -1,452 | -324 | -1,128 |
| Free Cash Flow | 33,879 | 30,672 | 26,157 | 9,178 | 42,393 |